COVID-19 in a pregnant kidney transplant recipient - what we need to know: A case report.
World J Transplant
; 12(10): 325-330, 2022 Oct 18.
Article
in English
| MEDLINE | ID: covidwho-2100240
ABSTRACT
BACKGROUND:
In the era of the coronavirus disease 2019 (COVID-19) pandemic, kidney tran splant recipients are more susceptible to severe acute respiratory syndrome co ronavirus (SARS-CoV-2) infection, developing severe morbidity and graft im pairment. Pregnant women are also more likely to develop severe COVID-19 di sease, causing pregnancy complications such as preterm births and acute kidney injury. CASESUMMARY:
Herein, we report the case of a pregnant woman with a third kidney tran splantation who developed COVID-19 disease. The reduction of immunosuppressive drugs and strict monitoring of trough blood levels were needed to avoid severe SARS-CoV-2-related complications, and permitted to continue a healthy pregnancy and maintain good graft function. In such a complex scenario, the con comitance of COVID-19-related morbidity, the risk of acute rejection in the hype rimmune recipient, graft dysfunction and pregnancy complications make the management of immunosuppression a very difficult task and clinicians must be aware.CONCLUSION:
Tailoring the immunosuppressive regimen is a key factor affecting both the graft outcome and pregnancy safety.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Case report
/
Prognostic study
Language:
English
Journal:
World J Transplant
Year:
2022
Document Type:
Article
Affiliation country:
Wjt.v12.i10.325
Similar
MEDLINE
...
LILACS
LIS